This treatment durability after withdrawal of therapy and survival effect of mTOR inhibition relative to MEK inhibition appeared to be more pronounced in immunogenic MOC1 tumor bearing mice compared to MOC2 tumor bearing mice. This evidence concerns the gene MTOR and neoplasm.